Basic Information
LncRNA/CircRNA Name | MYOSLID |
Synonyms | NA |
Region | GRCh38_2:207239650-207245887 |
Ensemble | ENSG00000229647 |
Refseq | NR_146555 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | head and neck squamous cell carcinoma |
ICD-0-3 | C76.0 |
Methods | qPCR, Western blot |
Sample | The HNSCC cell lines Cal27, SCC4 and SCC9, Tca8113 and the normal human immortalized oral keratinocyte line (HIOEC), OSCC tissues and adjacent normal tissues |
Expression Pattern | up-regulated |
Function Description | MYOSLID was identified as a Slug-related lncRNA and with prognostic value among the 9 overlapping DElncRNAs. GO and KEGG analyses revealed that MYOSLID was closely related to important biological processes and pathways that regulate cancer metastasis. The results of univariate and multivariate Cox regression analysis based on TCGA and HNSCC tissue microarray data suggested MYOSLID was an independent prognostic factor. MYOSLID expression in HNSCC was closely correlated with Slug, PDPN and LAMB3. The knockdown of MYOSLID in OSCC cell line significantly inhibited cell migration and invasion compared to those in the control cells. In addition, the knockdown of MYOSLID significantly reduced Slug, PDPN and LAMB3 expression levels. However, the knockdown of MYOSLID had no effect on the expression levels of the EMT biomarkers E-cadherin and Vimentin. |
Pubmed ID | 31238980 |
Year | 2019 |
Title | Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma |
External Links
Links for MYOSLID | GenBank HGNC NONCODE |
Links for head and neck squamous cell carcinoma | OMIM COSMIC |